Toggle navigation
Home
Search
Services
Blog
Contact
About
Identifying Ligands for A Novel Gabaa Receptor Subtype
Gee, Kelvin W.
Kadmus Pharmaceuticals, Inc., Irvine, CA, United States
Search 32 grants from Kelvin Gee
Search grants from Kadmus Pharmaceuticals, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Novel Non Nucleosidic HIV Reverse Transcriptase Inhibitor
Professional Nurse Traineeship
Uwm Cnc Initiative: Expanding Capacity for Primary Care
Molecular Neurogenetics of the No-ON-Transients a Locus
Biomedical Research Support Grant
Recently added grants:
Glial ion channels in glia/neurons interactions.
1/3 Lay-delivered Behavioral Activation in Senior Centers
Direct Intracranial Electrophysiological Mapping of Insular Circuits for Anxiety in the Human Brain
Studying the mammalian regulatory circuits by developing single-cell multi-omics technologies
Identifying effective and efficient approaches to tuberculosis screening in Brazilianprisons
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Small Business Technology Transfer (STTR) Grants - Phase I (R41)
Project #
3R41MH060527-01A1S1
Application #
6486311
Study Section
Special Emphasis Panel (ZRG1 (02))
Program Officer
Kelty, Miriam F
Project Start
2000-06-01
Project End
2002-05-31
Budget Start
2000-06-01
Budget End
2002-05-31
Support Year
1
Fiscal Year
2001
Total Cost
$7,023
Indirect Cost
Institution
Name
Kadmus Pharmaceuticals, Inc.
Department
Type
DUNS #
City
Irvine
State
CA
Country
United States
Zip Code
92612
Related projects
NIH 2001
R41 MH
Identifying Ligands for A Novel Gabaa Receptor Subtype
Gee, Kelvin W. / Kadmus Pharmaceuticals, Inc.
$7,023
NIH 2000
R41 MH
Identifying Ligands for A Novel Gabaa Receptor Subtype
Gee, Kelvin W. / Kadmus Pharmaceuticals, Inc.
$120,208
Comments
Be the first to comment on this grant